NG-641
AXP000039.1 · Oncolytic virus
- Platform
- adenovirus (Ad11p/Ad3 group B chimera, T-SIGn vector)
- Originator
- PsiOxus Therapeutics
- Sponsor
- Akamis Bio
Names
| Name | Type | Source |
|---|---|---|
| NG-641 | preferred name, code | curator, ncit |
Virus
- Role
- Oncolytic
- Family
- Adenoviridae
- Virus
- human adenovirus 11 (NCBI Taxonomy 10541)
- Strain
- Ad11p/Ad3 group B chimera (T-SIGn)
- Replication
- conditionally replicating
- Modifications
- enadenotucirev backbone carrying a multi-transgene cassette
- Transgenes
- FAP-TAc bispecific T-cell activator, CXCL9, CXCL10, IFNA2
- Route
- intravenous, intratumoral
- Source
- evidence
Cross-references
- NCI Thesaurus
- C168790
Approvals
No regulatory approval recorded.
Clinical trials (3)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT05043714 | Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours | Completed | Phase 1 | 2021-12-01 | 2023-11-13 | 30 | Epithelial Tumor; Metastatic Cancer |
| NCT04830592 | A Study of NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and Neck | Completed | Phase 1 | 2021-11-04 | 2023-12-07 | 36 | Squamous Cell Carcinoma of the Head and Neck |
| NCT04053283 | First in Human Study With NG-641, a Tumour Selective Transgene Expressing Adenoviral Vector | Completed | Phase 1 | 2020-01-23 | 2023-08-31 | 186 | Epithelial Tumor; Metastatic Cancer |
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 36897458 | A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studies. | Investigational new drugs | 2023 | cited by trial NCT04053283 |
Notes
Enadenotucirev backbone armed with a FAP/CD3 bispecific T-cell activator (FAP-TAc) plus CXCL9, CXCL10 and interferon alpha.
How to cite
NG-641 (AXP000039.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000039.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.